Impact of broadening trial eligibility criteria on the inclusion of patients with brain metastases in cancer clinical trials.

被引：0
|
作者：
Unger, Joseph M.
Xiao, Hong
Hershman, Dawn L.
Vaidya, Riha
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA USA
[2] Columbia Univ, Coll Phys & Surg, New York, NY USA
[3] SWOG Stat & Data Management Ctr, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1505
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022
    Xiao, Hong
    Vaidya, Riha
    Hershman, Dawn L.
    Unger, Joseph M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16) : 1953 - 1960
  • [2] Clinical Trial Eligibility Criteria and Recently Approved Cancer Therapies for Patients With Brain Metastases
    Tan, Aaron C.
    Boggs, Drexell H.
    Lee, Eudocia Q.
    Kim, Michelle M.
    Mehta, Minesh P.
    Khasraw, Mustafa
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [3] Use of modernized eligibility criteria in pancreatic cancer clinical trials.
    Riner, Andrea N.
    Freudenberger, Devon Clemons
    Herremans, Kelly M.
    Neal, Daniel W.
    Vudatha, Vignesh
    George, Thomas J.
    Trevino, Jose G.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Impact of prior cancer on eligibility for lung cancer clinical trials.
    Gerber, David E.
    Laccetti, Andrew L.
    Xuan, Lei
    Halm, Ethan
    Pruitt, Sandi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Uptake of recommendations for broadening clinical trial eligibility criteria for patients with brain metastasis and leptomeningeal disease in lung cancer clinical trials: A systematic review
    Riano, Ivy
    Velez, Maria Antonia
    Pomares-Millan, Hugo
    Manana, Ana I. Velazquez
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Evaluating the impact of performance status criteria on minority eligibility for oncology clinical trials.
    Bhandari, Sudip
    Mann, Jeremy
    Chawla, Jitesh
    Jain, Prerna
    Knight, Margot
    Lagor, Charles
    Mueller, Judith
    Raska, Paola
    Southwick, Steve
    Whyte, Warren
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18701 - E18701
  • [7] Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion
    Mercier, Benjamin D.
    Govindarajan, Ameish
    Castro, Daniela V.
    Li, Xiaochen
    Philip, Errol J.
    Feng, Matthew I.
    Prajapati, Sweta R.
    Chan, Elyse H.
    Lee, Kyle O.
    Sehgal, Ishaan
    Patel, Jalen
    O'Dell, Anna
    Chehrazi-Raffle, Alexander
    Ebrahimi, Hedyeh
    Rock, Adam
    Zengin, Zeynep Busra
    Meza, Luis A.
    Dizman, Nazli
    Hsu, Joann
    Liu, Sandy
    Dorff, Tanya B.
    Pal, Sumanta K.
    Tripathi, Abhishek
    CANCER MEDICINE, 2025, 14 (07):
  • [8] Laboratory eligibility criteria as potential barriers to participation by black men in prostate cancer clinical trials.
    Vastola, Marie
    Yang, David Dewei
    Mahal, Brandon Arvin Virgil
    Muralidhar, Vinayak
    Lathan, Christopher S.
    McGregor, Bradley Alexander
    Nguyen, Paul L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [9] Recommendations for Broadening Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials
    Siegel, Corey A.
    Rai, Victoria
    Outtier, An
    Vermeire, Severine
    Law, Cindy C. W.
    Sands, Bruce E.
    Abdulhamid, Asim
    Gearry, Richard
    McGuire, Josh
    Lindsay, James O.
    Panaccione, Remo
    Schweistein, Hagai
    Dotan, Iris
    Scarallo, Luca
    Griffiths, Anne
    Dubinsky, Marla C.
    JOURNAL OF CROHNS & COLITIS, 2024,
  • [10] Reappraisal of eligibility criteria in cancer clinical trials
    Penel, Nicolas
    Lebellec, Loic
    Vanseymortier, Marie
    CURRENT OPINION IN ONCOLOGY, 2018, 30 (05) : 352 - 357
12345